According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -NZ$43.51 M. In 2023 the company made an earning of -NZ$42.63 M an increase over its 2022 earnings that were of -NZ$60.51 M.The earnings displayed on this page is the company's Pretax Income.